Nanox Imaging Ltd. (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp. to support the deployment of the Nanox.ARC across New England. This move is part of Nanox's strategy to expand its U.S. channel partner network and increase the availability of its FDA-cleared, multisource 3D digital tomosynthesis system in outpatient and community-based clinical settings.
The agreement will see Associated X-Ray Imaging market, distribute, and support the Nanox.ARC, leveraging its established regional customer relationships and service infrastructure. By partnering with a well-entrenched distributor, Nanox aims to accelerate the adoption of its innovative imaging technology in a region known for its advanced healthcare landscape. This expansion is a critical step in Nanox's mission to drive the world's transition to preventive healthcare by making medical imaging more accessible beyond traditional hospital settings.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis system designed for ease of use and scalability. It is intended to enhance routine imaging workflows, support early detection of disease, and improve patient outcomes. The system is part of Nanox's broader ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts; and Nanox Health IT, which offers RIS, PACS, AI, dictation, and secure infrastructure solutions.
The importance of this expansion lies in its potential to democratize access to advanced imaging. By deploying the Nanox.ARC in community settings, Nanox aims to bridge the gap between hospital-based imaging and outpatient care, enabling earlier detection of diseases that are often asymptomatic in their initial stages. This aligns with the company's vision to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
According to the press release, the agreement with Associated X-Ray Imaging expands Nanox's U.S. channel partner network, which is expected to increase the reach of the Nanox.ARC in targeted markets. This partnership is particularly significant in New England, where there is a strong emphasis on healthcare innovation and quality. The region's dense population and high concentration of healthcare facilities make it an ideal market for introducing advanced imaging technologies that can be used in outpatient clinics and community health centers.
Nanox's approach integrates imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology to create a seamless solution from scan to interpretation. The company believes that by providing an end-to-end platform, it can reduce the complexity and cost associated with traditional imaging systems, thereby encouraging broader adoption and ultimately improving patient outcomes.
The expansion into New England is a testament to Nanox's commitment to growing its presence in the United States. With the support of Associated X-Ray Imaging, Nanox is poised to make its advanced imaging capabilities available to a wider range of healthcare providers, potentially revolutionizing how preventive screening is conducted in community settings. As the company continues to forge strategic partnerships, it strengthens its position in the medical imaging market and moves closer to its goal of making preventive healthcare accessible to all.
For more information about Nanox and its technologies, visit the company's newsroom at http://nnw.fm/NNOX.
